Dark genome cancer biology and bioinformatics
Nearly half of our DNA is made of transposable elements: ancient viral remnants and sequences that once copied themselves around the genome. We study what they do in cancer and blood disorders, and how they can help predict and treat disease.
- Endogenous retroviruses
- LINEs
- SINEs
- Protein-coding genes
What we do
See our research →Dark genome cancer biology
Transposable elements are usually kept silent, but in cancer they can switch back on. We map when and where this happens, which epigenetic pathways fail to hold them back, and how their activity shapes gene expression, inflammation and the immune response.
Because reactivated elements can produce new protein sequences, they are also a source of potential targets for T cell and antibody-based therapies.
Bioinformatics
Much of the dark genome is repetitive and hard to measure with standard pipelines. We build computational methods to quantify transposable element activity from sequencing data and integrate it with genomic, epigenomic and clinical information.
We use machine learning and visual analytics to turn these multi-omics datasets into predictive models, with a focus on haematological malignancies such as acute myeloid leukaemia.
Find your way around
- TeamThe people in the lab, what they work on and where to find them.
- ResearchOur main questions, from transposable elements in leukaemia to predictive models.
- PublicationsPapers from the lab, with links to read them.
- NewsNew papers, press coverage and what’s happening in the lab.
- FundersThe groups we work with and the organisations that support us.
- AlumniFormer lab members and where they are now.
- Join usOpen positions and how to get in touch about PhD, MSc or postdoc work.
- GalleryPhotos of the lab, our events and the people behind the work.
